HomeStock ListAnsell Ltd

Ansell Ltd

Closed

27.1 2.96

Overview

Share price change

24h

Current

Min

26.28

Max

27.43

Key metrics

By Trading Economics

Income

-65M

19M

Sales

-35M

785M

P/E

Sector Avg

14.696

EPS

0.409

Dividend yield

2.759

Profit margin

2.472

EBITDA

-43M

114M

Recommendations

By TipRanks

Rating Consensus

Neutral

12 Months Forecast

+11.87 upside

Dividends

By Dow Jones

Dividend Yield

Sector avg

2.76%

Market Stats

By TradingEconomics

Market Cap

-38M

3B

Previous open

24.14

Previous close

27.1

News Sentiment

By Acuity

35%

65%

Ansell Ltd chart

Related News

10 Apr 2024, 22:48 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition

10 Apr 2024, 21:40 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.

10 Apr 2024, 21:24 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 20:30 UTC

Top News
Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Investors Await Macquarie's FY 2025 Guidance -- Market Talk

10 Apr 2024, 22:57 UTC

Market Talk

Aussie Banks Unlikely to Get Upgrades Out of Earnings Season -- Market Talk

10 Apr 2024, 21:47 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 21:35 UTC

Top News

Buy the Stock Market's Inflation Freakouts -- Heard on the Street -- Update

10 Apr 2024, 21:09 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B -- Update

10 Apr 2024, 21:05 UTC

Market Talk

Mexican Stocks Close Lower; Peso Weakens Against Dollar -- Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 Apr 2024, 20:46 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal -- IBD

10 Apr 2024, 20:28 UTC

Market Talk

Only CPI Surprise, Big-Spending Budget Can Derail Canada Rate Cut in June -- Market Talk

10 Apr 2024, 20:27 UTC

Top News

Hot Inflation Report Weakens Case for Fed's June Rate Cut -- 8th Update

10 Apr 2024, 20:15 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B

10 Apr 2024, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 Apr 2024, 20:08 UTC

Market Talk

SPDR Gold Drops Following Inflation Data -- Market Talk

10 Apr 2024, 20:04 UTC

Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences: Vertex Will Acquire Alpine for $65 Per Shr or Approximately $4.9B in Cash, Transaction Approved by Both Boards of Directors, Anticipated to Close in 2Q >ALPN

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex Subsidiary Will Commence Cash Tender Offer to Purchase All Alpine Common Stk >VRTX

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Alpine Is Strategic Fit and Furthers Use of Scientific Innovation to Create Transformative Medicines Targeting Serious Diseases With High Unmet Need in Specialty Markets >VRTX

10 Apr 2024, 20:02 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Transaction Was Unanimously Approved by Both the Vertex and Alpine Boards

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Will Acquire Alpine for $65 Per Shr or About $4.9 B in Cash >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 19:58 UTC

Market Talk

Markets Largely Ignored BOC's Macklem's Remark on Possible June Cut -- Market Talk

10 Apr 2024, 19:10 UTC

Market Talk

U.S. Natural Gas Futures Eke Out Gains Ahead of Storage Report -- Market Talk

Ansell Ltd forecast

Price Target

By TipRanks

11.87% upside

12 Months Forecast

Average 26.725 AUD  11.87%

High 30.03 AUD

Low 25.726 AUD

Based on 6 Wall Street analysts offering 12 month price targets for Ansell Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

6 ratings

1

Buy

4

Hold

1

Sell

Sentiment

By Acuity

News Sentiment

Bullish Evidence

Volatility

Below average

News volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Ansell Ltd

Ansell Limited is an Australia-based safety protection solutions Company. It is engaged in development, manufacturing, sourcing, and distributing of gloves and personal protective equipments. The Company operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Industrial GBU manufactures hand and chemical protective clothing solutions for industrial applications. Industrial GBU offers protective solutions to various industries such as automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil, and gas. Healthcare GBU manufactures surgical and examination gloves, healthcare safety devices and infection prevention products for healthcare professionals and patients and single use industrial application gloves. Healthcare GBU offers solutions to customers including hospitals, dental surgeries, veterinary clinics, auto repair shops, chemical plants, laboratories, and pharmaceutical companies.